Lowering of body temperature affects human platelet functions and norepinephrine release.
The effect of lowering body temperature on plasma epinephrine, norepinephrine, and platelet density distribution and volume was studied in a placebo-controlled double-blind study. Lowering of body core temperature was induced by either exposure to a cold environment at a temperature of 5 degrees C (CT) or by a single dose of the 5-HT1A agonist ipsapirone (IPS). A third group exposed to an ambient temperature of 28 degrees C was given placebo (PLAC). All of the three groups were investigated in a climate chamber. In the CT group the density distribution of blood platelet subpopulations was shifted to an increase in less dense platelets that were more sensitive towards aggregation-inducing agents. The mean platelet volume in this subpopulation was decreased. Epinephrine was not affected, whereas the increase of norepinephrine was correlated with an increase of platelets that were more sensitive to aggregation-inducing agents in the CT group but not in the PLAC and IPS groups.
Opper
C
C
Institute of Physiological Chemistry, University of Marburg, Germany.
Hennig
J
J
Clement
C
C
Laschefski
U
U
Dey
D
D
Dieckwisch
J
J
Netter
P
P
Wesemann
W
W
D000328:Adult; D001792:Blood Platelets / Q000502:physiology*; D001831:Body Temperature / Q000502:physiology*; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood; D006801:Humans; D008297:Male; D009638:Norepinephrine / Q000097:blood*; D010976:Platelet Count; D010979:Platelet Function Tests; D011743:Pyrimidines / Q000494:pharmacology; D012044:Regression Analysis; D017366:Serotonin Receptor Agonists / Q000494:pharmacology
D011743:Pyrimidines; D017366:Serotonin Receptor Agonists; C043077:ipsapirone; D009638:Norepinephrine; D004837:Epinephrine